INSERM U773/CRB3, Faculté de Médecine X. Bichat, 16 Rue Henri Huchard, 75018 Paris, France.
Curr Drug Targets. 2012 Jan;13(1):103-15. doi: 10.2174/138945012798868434.
G protein coupled receptors (GPCRs) play a crucial role in physiology and pathophysiology in humans. Beside the large family A (rhodopsin-like receptors) and family C GPCR (metabotropic glutamate receptors), the small family B1 GPCR (secretin-like receptors) includes important receptors such as vasoactive intestinal peptide receptors (VPAC), pituitary adenylyl cyclase activating peptide receptor (PAC1R), secretin receptor (SECR), growth hormone releasing factor receptor (GRFR), glucagon receptor (GCGR), glucagon like-peptide 1 and 2 receptors (GLPR), gastric inhibitory peptide receptor (GIPR), parathyroid hormone receptors (PTHR), calcitonin receptors (CTR) and corticotropin-releasing factor receptors (CRFR). They represent very promising targets for the development of drugs having therapeutical impact on many diseases such as chronic inflammation, neurodegeneration, diabetes, stress and osteoporosis. Over the past decade, structure-function relationship studies have demonstrated that the N-terminal ectodomain (N-ted) of family B1 receptors plays a pivotal role in natural ligand recognition. Structural analysis of some family B1 GPCR N-teds revealed the existence of a Sushi domain fold consisting of two antiparallel β sheets stabilized by three disulfide bonds and a salt bridge. The family B1 GPCRs promote cellular responses through a signaling pathway including predominantly the Gsadenylyl cyclase-cAMP pathway activation. Family B1 GPCRs also interact with a few accessory proteins which play a role in cell signaling, receptor expression and/or pharmacological profiles of receptors. These accessory proteins may represent new targets for the design of new drugs. Here, we review the current knowledge regarding: i) the structure of family B1 GPCR binding domain for natural ligands and ii) the interaction of family B1 GPCRs with accessory proteins.
G 蛋白偶联受体(GPCRs)在人类的生理和病理生理学中起着至关重要的作用。除了大家族 A(视紫红质样受体)和家族 C GPCR(代谢型谷氨酸受体)外,小家族 B1 GPCR(分泌素样受体)还包括重要的受体,如血管活性肠肽受体(VPAC)、垂体腺苷酸环化酶激活肽受体(PAC1R)、分泌素受体(SECR)、生长激素释放因子受体(GRFR)、胰高血糖素受体(GCGR)、胰高血糖素样肽 1 和 2 受体(GLPR)、胃抑制肽受体(GIPR)、甲状旁腺激素受体(PTHR)、降钙素受体(CTR)和促肾上腺皮质激素释放因子受体(CRFR)。它们是开发具有治疗多种疾病(如慢性炎症、神经退行性疾病、糖尿病、应激和骨质疏松症)影响的药物的极具前景的靶点。在过去的十年中,结构-功能关系研究表明,家族 B1 受体的 N 端胞外域(N-ted)在天然配体识别中起着关键作用。一些家族 B1 GPCR N-ted 的结构分析表明,存在一个由两个反平行β片层组成的 Sushi 结构域折叠,由三个二硫键和一个盐桥稳定。家族 B1 GPCR 通过包括主要 Gs 腺苷酸环化酶-cAMP 途径激活的信号通路促进细胞反应。家族 B1 GPCR 还与一些辅助蛋白相互作用,这些蛋白在细胞信号转导、受体表达和/或受体的药理学特征中发挥作用。这些辅助蛋白可能代表设计新药物的新靶点。在这里,我们回顾了关于家族 B1 GPCR 天然配体结合域的结构和家族 B1 GPCR 与辅助蛋白相互作用的当前知识:i)家族 B1 GPCR 天然配体结合域的结构和 ii)家族 B1 GPCR 与辅助蛋白的相互作用。